CLINICAL THERAPEUTICS, vol. 17, n° 3, 1995, pages 534-540, 10 réf., ISSN 0149-2918, USA
HUNTER (K.A.) *, DORMAIER (G.K.)
In an effort to provide cost-effective pharmaceutical care at a 650-bed community hospital, a pharmacist-managed intravenous to oral step-down program was developed and implemented.
As part of this program, satellite pharmacists review daily the charts of patients receiving 1 or more of 10 targeted drugs given intravenously.
Based on a predetermined set of criteria and their clinical judgment, pharmacists recommend that physicians switch to the oral formulation of the targeted drugs if appropriate.
This program has been in place for 7 months, during which time 223 recommendations were made.
Of these recommendations, 190 were accepted and implemented, resulting in a cost savings of $21,596.00.
When annualized, the expected savings is $37,000.00 or nearly the salary of one full-time pharmacist.
This program has been well accepted by physicians and pharmacists.
It appears to be having a positive impact on physician awareness of using oral medications when appropriate.
Mots-clés BDSP : Pharmacien, Hôpital, Etats Unis, Homme, Thérapeutique, Economie santé, Amérique
Mots-clés Pascal : Pharmacien, Hôpital, Etats Unis, Homme, Voie intraveineuse, Voie orale, Traitement, Analyse coût, Economie santé, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Chemist, Hospital, United States, Human, Intravenous administration, Oral administration, Treatment, Cost analysis, Health economy, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0454447
Code Inist : 002B30A07B. Création : 01/03/1996.